Nov. 10 - 13, 2021 (Boston, MA)
Patient-friendly remote clinical research has never been more crucial to the future of drug development. We are proud to be one of the 100 founding members of the Decentralized Research Alliance and are beyond eager to being collaboration with other industry leaders to expedite the adoption of decentralized clinical trials. We look forward to the first-even in-person DTRA leadership council meeting in Boston.
ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.
Up to 4x
3 mo ObvioHealth average vs 12 mo benchmark for site-based trials
average retention vs. 70% benchmark for traditional trials
average per study (digital questionnaires, daily ediary, etc.).